IRB #

STUDY00019915

Title

[NMDP - BMT CTN MOU] CTN 1704: Composite Health Assessment Model for Older Adults: Applying Pre-Transplant Comorbidity, Geriatric Assessment, and Biomarkers to Predict Non-Relapse Mortality after Allogeneic Transplantation (CHARM)

Principal Investigator

Richard Maziarz

Study Purpose

We are doing this study to learn how well patients do after transplant, based on their health before transplant.

Medical Condition(s)

allogeneic transplant, blood cancer

Eligibility Criteria

Over the age of 60
Receiving an allogeneic stem cell transplant to treat blood cancer

Age Range

60 - 120

Healthy Volunteers Needed

No

Duration of Participation

1 year

Minors Included

No

Contact

Clinical Trials Information Line: Phone 503-494-1080 or trials@ohsu.edu

Sponsor

Bone Marrow Transplant Clinical Trials Network

Recruitment End

01/01/2025

Compensation Provided

No


Go Back